Alnylam Pharmaceuticals
ALNY
ALNY
418 hedge funds and large institutions have $16.5B invested in Alnylam Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 131 increasing their positions, 159 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
18% less repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 159
21% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 68
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
418
Holding in Top 10
6
Calls
$486M
Puts
$346M
Top Buyers
| 1 | +$626M | |
| 2 | +$238M | |
| 3 | +$90.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$48.6M |
| 5 |
Morgan Stanley
New York
|
+$40.8M |
Top Sellers
| 1 | -$251M | |
| 2 | -$178M | |
| 3 | -$131M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$117M |
| 5 |
JPMorgan Chase & Co
New York
|
-$92.7M |